1-15 of 463
Communicating Pathologic Response Results in Resectable NSCLC
Project Oncology®Communicating Pathologic Response Results in Resectable NSCLC
Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Project Oncology®Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Managing Immune-Related Adverse Events in Metastatic NSCLC
Project Oncology®Managing Immune-Related Adverse Events in Metastatic NSCLC
Managing High-Risk Subgroups in Metastatic NSCLC
Project Oncology®Managing High-Risk Subgroups in Metastatic NSCLC
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Project Oncology®Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Emerging Therapeutic Strategies in Metastatic NSCLC
Project Oncology®Emerging Therapeutic Strategies in Metastatic NSCLC
- advertisement
Turning Cold Tumors Hot with mRNA COVID-19 Vaccines
COVID-19: On The FrontlinesTurning Cold Tumors Hot with mRNA COVID-19 Vaccines
Evaluating High-Flow Nasal Cannula in Acute Hypercapnic Respiratory Failure
Clinician's RoundtableEvaluating High-Flow Nasal Cannula in Acute Hypercapnic Respiratory Failure
Identifying and Treating Severe Asthma Patients with Biologics
Clinician's RoundtableIdentifying and Treating Severe Asthma Patients with Biologics
COPD-OSA Overlap: Diagnostic and Management Gaps
Clinician's RoundtableCOPD-OSA Overlap: Diagnostic and Management Gaps
RSV Hospitalization: Cardiorespiratory Risk in Adults
AudioAbstractsRSV Hospitalization: Cardiorespiratory Risk in Adults
- advertisement
Key Updates in Bronchoscopic Interventions for COPD Care
Clinician's RoundtableKey Updates in Bronchoscopic Interventions for COPD Care
Endobronchial Valve Therapy in COPD: Selection Criteria and Safety Insights
Clinician's RoundtableEndobronchial Valve Therapy in COPD: Selection Criteria and Safety Insights
Identifying the Respiratory Manifestations of TK2d: The Pulmonologist’s Role
NeuroFrontiersIdentifying the Respiratory Manifestations of TK2d: The Pulmonologist’s Role





























































